CAPRICOR THERAPEUTICS, INC. Notes Payable, Noncurrent
CAPRICOR THERAPEUTICS, INC. (CAPR) had Notes Payable, Noncurrent of $0 as of 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes and Loans, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2022-03-11
- 2021-12-31: Notes Payable, Noncurrent $0.00.
- 2021-09-30: Notes Payable, Noncurrent $0.00.
- 2021-06-30: Notes Payable, Noncurrent $0.00.
- 2021-03-31: Notes Payable, Noncurrent $35.47K.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-11 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-13 |
| 2021-03-31 | $35.47K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $71.47K 10-K · filed 2022-03-11 |
| 2020-09-30 | $124.92K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $178.23K 10-Q · filed 2020-08-10 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |